Document:

Exhibit 10.16

 

THIS WARRANT AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE SECURITIES ACT AND IS QUALIFIED UNDER APPLICABLE
STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE SECURITIES
ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY
TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.

 

LYTUS TECHNOLOGIES HOLDING PTV. LTD.

WARRANT

TO PURCHASE COMMON SHARES

 

 

Warrant Certificate No.: 

Original Issue Date: 

Expiration Date: 

 

FOR VALUE RECEIVED,
Lytus Technologies Holding PTV. LTD., a British Virgin Islands private limited company (the “Company”), hereby certifies
_______, or its registered assigns (the “Holder”), is entitled to purchase from the Company up to 500,000 shares of
common shares of the Company, par value $0.01 per share (the “Common Shares”), or, in the event the securities sold
to investors in the Qualified IPO (defined below) are units consisting of both Common Shares and warrants to purchase Common Shares, or
any other combination of securities, this Warrant shall be exercisable into a number of units sold in such Qualified IPO equal to the
number of Common Shares that would otherwise have been purchasable upon exercise of this Warrant, subject to the conditions and adjustments
set forth below. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined
below. This Warrant is issued by the Company pursuant to the Company’s bridge financing described in the related Subscription Agreement
of even date herewith (the “Subscription Agreement”).

 

1. Definitions. As
used in this Warrant, the following terms have the respective meanings set forth below:

 

“Affiliate”
means, as applied to any Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control
with, such Person, or is a family member related by birth or marriage. For purposes of this definition only, “control” means
the possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership
of equity interests, by contract, or otherwise; provided, however, that, in any event: (i) any Person who owns directly or indirectly
fifty percent (50%) or more of the securities having ordinary voting power for the election of directors or other members of the governing
body of a Person or fifty percent (50%) or more of the partnership, member or other ownership interests of a Person (other than as a limited
partner of such Person) shall be deemed to control such Person; and (ii) each director (or manager) of a Person shall be deemed to be
an Affiliate of such Person.

 

“Aggregate
Exercise Price” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is
then being exercised pursuant to Section 3 hereof, multiplied by (b) the Exercise Price.

 

“Board” means the board of directors of the Company.

 

     

     

    

 

“Business
Day” means any day, except a Saturday, Sunday or legal holiday on which banking institutions in the city of New York are authorized
or obligated by law or executive order to close.

 

“Common Shares”
means the common shares, par value $0.01 per share, of the Company, and any capital stock into which such Common Shares shall have been
converted, exchanged or reclassified following the date hereof.

 

“Common
Shares Deemed Outstanding” means the number of outstanding shares of Common Shares, assuming conversion of all outstanding Convertible
Securities into shares of Common Shares, the exercise of all outstanding Options, or other securities convertible in to Common Shares,
as well as the shares of Common Shares reserved for issuance under any existing Company equity incentive plan; provided, that Common
Shares Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its
wholly owned subsidiaries.

 

“Company” has the meaning set forth
in the preamble.

 

“Convertible
Securities” means any securities (directly or indirectly) convertible into or exchangeable for Common Shares, but excluding
Options.

 

“Exchange Act” means the Securities Exchange
Act of 1934, as amended.

 

“Excluded Issuances”
means any issuance or sale (or deemed issuance or sale in accordance with Section 4(d)) by the Company after the Original Issue Date of:
(a) shares of Common Shares issued upon the exercise of this Warrant; (b) up to an aggregate of 1,000,000 shares of Common Shares (as
such number of shares is equitably adjusted for subsequent stock splits, reverse stock splits, stock combinations, stock dividends and
recapitalizations) issued directly or upon the exercise of Options to directors, officers, employees, or consultants of the Company in
connection with their service as directors of the Company, their employment by the Company or their retention as consultants by the Company,
in each case authorized by the Board and issued pursuant to the Lytus Technologies Employee Incentive Plan; or (c) shares of Common Shares
issued upon the conversion or exercise of Options (other than Options covered by clause (b) above) or Convertible Securities issued prior
to the Original Issue Date, provided that such securities are not amended after the date hereof to increase the number of shares of Common
Shares issuable thereunder or to lower the exercise or conversion price thereof; (d) shares of Common Shares, Options or Convertible Securities
issued (i) to persons in connection with a joint venture, strategic alliance or other commercial relationship with such person (including
persons that are customers, suppliers and strategic partners of the Company) relating to the operation of the Company's business and not
for the primary purpose of raising equity capital, (ii) in connection with a transaction in which the Company, directly or indirectly,
acquires another business or its tangible or intangible assets, or (iii) to lenders as equity kickers in connection with debt financings
of the Company, in each case where such transactions have been approved by the Board; (e) shares of Common Shares in an offering for cash
for the account of the Company that is underwritten on a firm commitment basis and is registered with the Securities and Exchange Commission
under the Securities Act of 1933, as amended; or (f) shares of Common Shares, Options or Convertible Securities issued to the lessor or
vendor in any office lease or equipment lease or similar equipment financing transaction in which the Company obtains the use of such
office space or equipment for its business.

 

“Exercise Date”
means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in Section 3 shall have
been satisfied at or prior to 5:00 p.m., New York, New York time, on a Business Day, including, without limitation, the receipt by the
Company of the Exercise Agreement, the Warrant and the Aggregate Exercise Price.

 

“Exercise Agreement” has the meaning set
forth in Section 3(a)(i).

 

“Exercise Period” has the meaning set forth in Section 2.

 

    2

     

    

 

“Exercise
Price” shall mean (a) if six months have elapsed since a Qualified IPO has occurred, the lesser of: (i) one hundred and ten
percent (110%) of the price of the Qualified IPO and (ii) the lowest daily VWAP (as defined below) during the ten trading days prior to
exercise of this Warrant; (b) if six months have not elapsed since a Qualified IPO, one hundred and ten percent (110%) of the price of
the Qualified IPO; or (c) if a Qualified IPO has not occurred $10.00

 

“Maximum Percentage” has the meaning set
forth in Section 3(i).

 

“Options”
means any warrants or other rights or options to subscribe for or purchase Common Shares or Convertible Securities.

 

“Original Issue
Date” means the date on which the Warrant was issued by the Company pursuant to the Subscription Agreement.

 

“Nasdaq” means The Nasdaq Stock Market
LLC.

 

“Person”
means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization
or government or department or agency thereof.

 

“Qualified
IPO” has the meaning set forth in that certain Secured Promissory Note of even date herewith issued by the Company to the Holder.

 

“Registration
Statement” means any registration statement filed by the Company under the Securities Act, any amendments and supplements to
such registration statement, including post- effective amendments, and all exhibits and all material incorporated by reference in such
registration statement.

 

“Trading Day”
means (a) a day on which the Common Shares is traded on the Nasdaq Capital Market or another National Securities Exchange, or (b) if the
Common Shares is not traded on the Nasdaq Capital Market or another National Securities Exchange, a day on which the Common Shares is
quoted in the over the counter market as reported by the National Quotation Bureau Incorporated (or any similar organization or agency
succeeding its functions of reporting prices); provided, however, that in the event that the Common Shares is not listed or quoted as
set forth in (a) or (b) of this definition, then Trading Day shall mean any day except Saturday, Sunday and any day which shall be a legal
holiday or a day on which banking institutions in the State of New York are authorized or required by law or other government action to
close.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date)
on the Trading Market on which the Common Shares is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of a share of Common Shares for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if the Common
Shares is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for the Common Shares are then reported in the “Pink
Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent bid price per share of the Common Shares so reported, or (d) in all other cases, the fair market value of a share of Common
Shares as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.

 

“Warrant”
means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.

 

    3

     

    

 

“Warrant
Shares” means the shares of Common Shares or other capital stock of the Company then purchasable upon exercise of this Warrant
in accordance with the terms of this Warrant. Notwithstanding anything contained herein, in the event the securities sold to investors
in the Qualified IPO are units consisting of both Common Shares and warrants to purchase Common Shares, or any other combination of securities,
this Warrant shall be exercisable into a number of units sold in such Qualified IPO equal to the number of Common Shares that would otherwise
have been purchasable upon exercise of this Warrant. In such event, the Company will issue a new warrant to the Holder evidencing the
rights of the Holder to purchase the specific number of Warrant Shares and attendant exercise prices applicable with respect to this Warrant.

 

2. Term
of Warrant. Subject to the terms and conditions hereof, at any time or from time to time after the six month anniversary of the Qualified
IPO and prior to 5:00 p.m., New York, New York time, on the third (3rd) anniversary of the Qualified IPO or, if such day is not a Business
Day, on the next preceding Business Day (the “Exercise Period”), the Holder of this Warrant may exercise this Warrant
for all or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).

 

3.
Exercise of Warrant.

 

(a) Exercise
Procedure. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part of
the unexercised Warrant Shares, upon:

 

(i) surrender
of this Warrant to the Company at its then principal executive offices (or an indemnification undertaking with respect to this Warrant
in the case of its loss, theft or destruction), together with an Exercise Agreement in the form attached hereto as Exhibit A
(each, an “Exercise Agreement”), duly completed (including specifying the number of Warrant Shares to be purchased)
and executed; and

 

(ii) payment
to the Company of the Aggregate Exercise Price in accordance with Section 3(b).

 

(b) Payment
of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as expressed in
the Exercise Agreement, by the following methods:

 

(i) by
delivery to the Company of a certified or official bank check payable to the order of the Company or by wire transfer of immediately available
funds to an account designated in writing by the Company, in the amount of such Aggregate Exercise Price;

 

(ii) by
instructing the Company to issue Warrant Shares then issuable upon exercise of all or any part of this Warrant on a net basis such that,
without payment of any cash consideration or other immediately available funds, the Holder shall surrender this Warrant in exchange for
the number of Warrant Shares as is computed using the following formula:

 

X = Y(A - B) ÷
A

 

Where:

 

X = the number of Warrant Shares to be issued to the Holder.

 

Y = the total number of Warrant Shares
for which the Holder has elected to exercise this Warrant pursuant to Section 3(a).

 

A = the VWAP on the Trading Day immediately
preceding the date on which Holder elects to exercise this Warrant.

 

B = the Exercise Price in effect under this
Warrant as of the applicable Exercise Date;

 

    4

     

    

 

(iii) by
surrendering to the Company (x) Warrant Shares previously acquired by the Holder with an aggregate VWAP on the Trading Day immediately
preceding the date on which Holder elects to exercise this Warrant equal to such Aggregate Exercise Price and/or (y) other securities
of the Company having a value as of the Exercise Date equal to the Aggregate Exercise Price (which value in the case of debt securities
shall be the principal amount thereof plus accrued and unpaid interest, in the case of preferred stock shall be the liquidation value
thereof plus accumulated and unpaid dividends and in the case of shares of Common Shares shall be the Fair Market Value thereof); or

 

(iv) any
combination of the foregoing.

 

In the event of any withholding of Warrant Shares or surrender of other equity securities pursuant to
clause (ii), (iii) or (iv) above where the number of shares whose value is equal to the Aggregate Exercise Price is not a whole
number, the number of shares withheld by or surrendered to the Company shall be rounded up to the nearest whole share and the
Company shall make a cash payment to the Holder (by delivery of a certified or official bank check or by wire transfer of
immediately available funds) based on the incremental fraction of a share being so withheld by or surrendered to the Company in an
amount equal to the product of (x) such incremental fraction of a share being so withheld or surrendered multiplied by (y) in the
case of Common Shares, the Fair Market Value per Warrant Share as of the Exercise Date, and, in all other cases, the value thereof
as of the Exercise Date determined in accordance with clause (iii)(y) above.

 

(c) Delivery
of Share Certificates. Upon receipt by the Company of the Exercise Agreement, surrender of this Warrant and payment of the Aggregate
Exercise Price (in accordance with Section 3(a) hereof), the Company shall, as promptly as practicable, and in any event within two (2)
Business Days thereafter, execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder a certificate or certificates
representing the Warrant Shares issuable upon such exercise, together with cash in lieu of any fraction of a share, as provided in Section
3(d) hereof. The share certificate or certificates so delivered shall be, to the extent possible, in such denomination or denominations
as the exercising Holder shall reasonably request in the Exercise Agreement and shall be registered in the name of the Holder or, subject
to compliance with Section 5 below, such other Person’s name as shall be designated in the Exercise Agreement. This Warrant shall
be deemed to have been exercised and such certificate or certificates of Warrant Shares shall be deemed to have been issued, and the Holder
or any other Person so designated to be named therein shall be deemed to have become a holder of record of such Warrant Shares for all
purposes, as of the Exercise Date.

 

(d) Fractional
Shares. The Company shall not be required to issue a fractional Warrant Share upon exercise of any Warrant. As to any fraction of
a Warrant Share that the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either
pay to such Holder a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise
Price or round up to the next whole share.an amount in cash.

 

(e) Delivery
of New Warrant. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised, the
Company shall, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued in accordance with
Section 3(c) hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and unexercised
Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.

 

    5

     

    

 

(f) Valid
Issuance of Warrant and Warrant Shares; Payment of Taxes. With respect to the exercise of this warrant, the Company hereby represents,
covenants and agrees:

 

(i) This
Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized and validly
issued.

 

(ii) All
Warrant Shares issuable upon the exercise of this Warrant pursuant to the terms hereof shall be, upon issuance, and the Company shall
take all such actions as may be necessary or appropriate in order that such Warrant Shares are, validly issued, fully paid and non- assessable,
issued without violation of any preemptive or similar rights of any shareholder of the Company and free and clear of all taxes, liens
and charges.

 

(iii) The
Company shall take all such actions as may be necessary to ensure that all such Warrant Shares are issued without violation by the Company
of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which shares of Common Shares
or other securities constituting Warrant Shares may be listed at the time of such exercise (except for official notice of issuance which
shall be immediately delivered by the Company upon each such issuance).

 

(iv) The
Company shall use its best efforts to cause the Warrant Shares, immediately upon such exercise, to be listed on any domestic securities
exchange upon which shares of Common Shares or other securities constituting Warrant Shares are listed at the time of such exercise.

 

(v) The
Company shall pay all expenses in connection with, and all taxes and other governmental charges that may be imposed with respect to, the
issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not be required to pay any
tax or governmental charge that may be imposed with respect to any applicable withholding or the issuance or delivery of the Warrant Shares
to any Person other than the Holder, and no such issuance or delivery shall be made unless and until the Person requesting such issuance
has paid to the Company the amount of any such tax, or has established to the satisfaction of the Company that such tax has been paid.

 

(g) Conditional
Exercise. Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection with
a public offering or a sale of the Company (pursuant to a merger, sale of stock, or otherwise), such exercise may at the election of the
Holder be conditioned upon the consummation of such transaction, in which case such exercise shall not be deemed to be effective until
immediately prior to the consummation of such transaction.

 

(h) Reservation
of Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but unissued
Common Shares or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant, two
times the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and the par value per Warrant Share shall at all
times be less than or equal to the applicable Exercise Price. The Company shall not increase the par value of any Warrant Shares receivable
upon the exercise of this Warrant above the Exercise Price then in effect, and shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Shares upon the exercise of this
Warrant.

 

(i) Warrant Share
Limitations. If Holder enters into an Exercise Agreement, Holder shall have no right to purchase Warrant Shares, and the Company
shall not issue Warrant Shares, in an amount that would cause Holder to beneficially own in excess of 9.99% (the “Maximum
Percentage”) of all shares then outstanding immediately after giving effect to such purchase. For purposes of the
foregoing sentence, the aggregate number of shares beneficially owned by Holder and its affiliates shall include the number of
shares of Common Shares issuable upon the consummation of the Exercise Agreement, but shall exclude shares of Common Shares which
would be issuable upon exercise or conversion of the unexercised or unconverted portion of any other securities of the Company
beneficially owned by Holder and its affiliates (including, without limitation, any convertible notes or convertible preferred
stock) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the
preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the
Exchange Act. The number of outstanding shares shall be determined after giving effect to the conversion or exercise of securities
of the Company, by a holder thereof and its affiliates since the date as of which such number of outstanding shares was reported. By
written notice to the Company, Holder may from time to time increase or decrease the Maximum Percentage to any other percentage
specified in such notice; provided that (i) any such increase will not be effective until the sixty-first (61st) day after such
notice is delivered to the Company, and (ii) any such increase or decrease will apply only to Holder.

 

    6

     

    

 

4. Adjustment
to Number of Warrant Shares. In order to prevent dilution of the purchase rights granted under this Warrant, the number of Warrant
Shares issuable upon exercise of this Warrant shall be subject to the adjustment from time to time as provided in this Section 4 (in each
case, after taking into consideration any prior adjustments pursuant to this Section 4).

 

(a) Adjustment
to Exercise Price Upon Issuance of Common Shares. Except as provided in Section 4(c) and except in the case of an event described
in either Section 4(e) or Section 4(f), if the Company shall, at any time or from time to time after the Original Issue Date, issue or
sell, or in accordance with Section 4(d) is deemed to have issued or sold, any shares of Common Shares without consideration or for consideration
per share less than the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale), then immediately
upon such issuance or sale (or deemed issuance or sale), the Exercise Price in effect immediately prior to such issuance or sale (or deemed
issuance or sale) shall be reduced (and in no event increased) to an Exercise Price equal to the quotient obtained by dividing:

 

(i) the
sum of (A) the product obtained by multiplying the Common Shares Deemed Outstanding immediately prior to such issuance or sale (or deemed
issuance or sale) by the Exercise Price then in effect plus (B) the aggregate consideration, if any, received by the Company upon such
issuance or sale (or deemed issuance or sale); by

 

(ii) the
sum of (A) the Common Shares Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus (B) the aggregate
number of shares of Common Shares issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed issuance
or sale).

 

(b) Adjustment
to Number of Warrant Shares Upon Adjustment to Exercise Price. Upon any and each adjustment of the Exercise Price as provided in Section
4(a), the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment shall be increased
to a number of Warrant Shares equal to the quotient obtained by dividing:

 

(i) the
product of (A) the Exercise Price in effect immediately prior to any such adjustment multiplied by (B) the number of Warrant Shares issuable
upon exercise of this Warrant immediately prior to any such adjustment; by

 

(ii)
the Exercise Price resulting from such adjustment.

 

(c) Exceptions
To Adjustment Upon Issuance of Common Shares. Anything herein to the contrary notwithstanding, there shall be no adjustment to the
Exercise Price or the number of Warrant Shares issuable upon exercise of this Warrant with respect to any Excluded Issuance.

 

(d) Effect
of Certain Events on Adjustment to Exercise Price. For purposes of determining the adjusted Exercise Price under Section 4(a) hereof,
the following shall be applicable:

 

(i) Issuance of
Options. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant or sell
(whether directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or
exchange any Convertible Securities issuable upon the exercise of such Options are immediately exercisable, and the lowest price per
share (determined as provided in this paragraph and in Section 4(d)(v) for which any one share of Common Shares is issuable upon the
exercise of any such Option or upon the conversion or exchange of any Convertible Security issuable upon the exercise of any such
Option is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Options, then such
share of Common Shares issuable upon the exercise of such Option or upon conversion or exchange of such Convertible Security
issuable upon the exercise of such Option shall be deemed to have been issued as of the date of granting or sale of such Options
(and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price under Section 4(a)), at a price per
share equal to such lowest price per share. For purposes of this Section 4(d)(i) , the lowest price per share for which any one
share of Common Shares is issuable upon the exercise of any such Option or upon the conversion or exchange of any Convertible
Security issuable upon the exercise of any such Option shall be equal to the sum (which sum shall constitute the applicable
consideration received for purposes of Section 4(a)) of the lowest amounts of consideration, if any, received or receivable by the
Company as consideration with respect to any one share of Common Shares upon each of (A) the granting or sale of the Option, plus
(B) the exercise of the Option, plus (C) in the case of an Option which relates to Convertible Securities, the issuance or sale of
the Convertible Security and the conversion or exchange of the Convertible Security. Except as otherwise provided in Section
4(d)(iii), no further adjustment of the Exercise Price shall be made upon the actual issuance of Common Shares or of Convertible
Securities upon exercise of such Options or upon the actual issuance of Common Shares upon conversion or exchange of Convertible
Securities issuable upon the exercise of such Options.

 

    7

     

    

 

(ii) Issuance
of Convertible Securities. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant
or sell (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or
exchange any such Convertible Securities is immediately exercisable, and the lowest price per share (determined as provided in this paragraph
and in Section 4(d)(v) for which one share of Common Shares is issuable upon the conversion or exchange of any such Convertible Securities
is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Convertible Securities, then such
share of Common Shares issuable upon conversion or exchange of such Convertible Security shall be deemed to have been issued as of the
date of granting or sale of such Convertible Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting the
Exercise Price under Section 4(a)), at a price per share equal to such lowest price per share. For purposes of this Section 4(d)(ii),
the lowest price per share for which any one share of Common Shares is issuable upon the conversion or exchange of any such Convertible
Security shall be equal to the sum (which sum shall constitute the applicable consideration received for purposes of Section 4(a)) of
the lowest amounts of consideration, if any, received or receivable by the Company as consideration with respect to any one share of Common
Shares upon each of (A) the granting or sale of the Convertible Security, plus (B) the conversion or exchange of the Convertible Security.
Except as otherwise provided in Section 4(d)(iii), no further adjustment of the Exercise Price shall be made upon the actual issuance
of Common Shares upon conversion or exchange of such Convertible Securities or by reason of the issue or sale of Convertible Securities
upon exercise of any Options to purchase any such Convertible Securities for which adjustments of the Exercise Price have been made pursuant
to the other provisions of this Section 4(d).

 

(iii) Change in
Terms of Options or Convertible Securities. Upon any change in any of (A) the lowest amounts of consideration, if any, received
or receivable by the Company as consideration with respect to any one share of Common Shares upon the granting or sale of any
Options or Convertible Securities referred to in Section 4(d)(i) or Section 4(d)(ii) hereof, (B) the lowest amounts of additional
consideration, if any, payable to the Company with respect to any one share of Common Shares upon exercise of any Options or upon
the issuance, conversion or exchange of any Convertible Securities referred to in Section 4(d)(i) or Section 4(d)(ii) hereof, (C)
the rate at which Convertible Securities referred to in Section 4(d)(i) or Section 4(d)(ii) hereof are convertible into or
exchangeable for Common Shares, or (D) the maximum number of shares of Common Shares issuable in connection with any Options
referred to in Section 4(d)(i) hereof or any Convertible Securities referred to in Section 4(d)(ii) hereof (in each case, other than
in connection with an Excluded Issuance), then (whether or not the original issuance or sale of such Options or Convertible
Securities resulted in an adjustment to the Exercise Price pursuant to this Section 4) the Exercise Price in effect at the time of
such change shall be adjusted or readjusted, as applicable, to the Exercise Price which would have been in effect at such time
pursuant to the provisions of this Section 4 had such Options or Convertible Securities still outstanding provided for such changed
consideration, conversion rate or maximum number of shares, as the case may be, at the time initially granted, issued or sold, but
only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced, and the number of Warrant
Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment or readjustment shall be correspondingly
adjusted or readjusted pursuant to the provisions of Section 4(b).

 

    8

     

    

 

(iv) Treatment
of Expired or Terminated Options or Convertible Securities. Upon the expiration or termination of any unexercised Option (or portion
thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its original
issuance or upon a revision of its terms) was made pursuant to this Section 4 (including without limitation upon the redemption or purchase
for consideration of all or any portion of such Option or Convertible Security by the Company), the Exercise Price then in effect hereunder
shall forthwith be changed pursuant to the provisions of this Section 4 to the Exercise Price which would have been in effect at the time
of such expiration or termination had such unexercised Option (or portion thereof) or unconverted or unexchanged Convertible Security
(or portion thereof), to the extent outstanding immediately prior to such expiration or termination, never been issued.

 

(v) Calculation
of Consideration Received. If the Company shall, at any time or from time to time after the Original Issue Date, issue or sell,
or is deemed to have issued or sold in accordance with Section 4(d), any shares of Common Shares, Options or Convertible Securities:
(A) for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor; (B) for
consideration other than cash, the amount of the consideration other than cash received by the Company shall be the fair value of
such consideration, except where such consideration consists of marketable securities, in which case the amount of consideration
received by the Company shall be the market price (as reflected on any securities exchange, quotation system or association or
similar pricing system covering such security) for such securities as of the end of business on the date of receipt of such
securities; (C) for no specifically allocated consideration in connection with an issuance or sale of other securities of the
Company, together comprising one integrated transaction, the amount of the consideration therefor shall be deemed to be the fair
value of such portion of the aggregate consideration received by the Company in such transaction as is attributable to such shares
of Common Shares, Options or Convertible Securities, as the case may be, issued in such transaction/; or (D) to the owners of the
non-surviving entity in connection with any merger in which the Company is the surviving corporation, the amount of consideration
therefor shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is
attributable to such shares of Common Shares, Options or Convertible Securities, as the case may be, issued to such owners. The net
amount of any cash consideration and the fair value of any consideration other than cash or marketable securities shall be
determined in good faith jointly by the Board and the Holder.

 

(vi) Record Date. For
purposes of any adjustment to the Exercise Price or the number of Warrant Shares in accordance with this Section 4, in case the
Company shall take a record of the holders of its Common Shares for the purpose of entitling them (A) to receive a dividend or other
distribution payable in Common Shares, Options or Convertible Securities or (B) to subscribe for or purchase Common Shares, Options
or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of the shares of Common Shares
deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the
granting of such right of subscription or purchase, as the case may be[; provided, that if before the distribution to its holders of
Common Shares the Company legally abandons its plan to pay or deliver such dividend, distribution, subscription or purchase rights,
then thereafter no adjustment shall be required by the taking of such record and any such adjustment previously made in respect
thereof shall be rescinded and annulled.

 

    9

     

    

 

(vii) Dividends
and Distributions. Subject to the provisions of this Section 4(d), If the Company shall, at any time or from time to time after the
Original Issue Date, make or declare, or fix a record date for the determination of holders of Common Shares entitled to receive, a dividend
or any other distribution payable in securities of the Company (other than a dividend or distribution of shares of Common Shares, Options
or Convertible Securities in respect of outstanding shares of Common Shares), cash or other property, then, and in each such event, provision
shall be made so that the Holder shall receive upon exercise of the Warrant, in addition to the number of Warrant Shares receivable thereupon,
the kind and amount of securities of the Company, cash or other property which the Holder would have been entitled to receive had the
Warrant been exercised in full into Warrant Shares on the date of such event and had the Holder thereafter, during the period from the
date of such event to and including the Exercise Date, retained such securities, cash or other property receivable by them as aforesaid
during such period, giving application to all adjustments called for during such period under this Section Error! Reference source
not found. with respect to the rights of the Holder; provided, that no such provision shall be made if the Holder receives, simultaneously
with the distribution to the holders of Common Shares, a dividend or other distribution of such securities, cash or other property in
an amount equal to the amount of such securities, cash or other property as the Holder would have received if the Warrant had been exercised
in full into Warrant Shares on the date of such event.

 

(e) Adjustment
to Number of Warrant Shares Upon Dividend, Subdivision or Combination of Common Shares. If the Company shall, at any time or from
time to time after the Original Issue Date, (i) pay a dividend or make any other distribution upon the Common Shares or any other capital
stock of the Company payable in shares of Common Shares or in Options or Convertible Securities, or (ii) subdivide (by any stock split,
recapitalization or otherwise) its outstanding shares of Common Shares into a greater number of shares, the number of Warrant Shares issuable
upon exercise of this Warrant immediately prior to any such dividend, distribution or subdivision shall be proportionately increased.
If the Company at any time combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Shares into a
smaller number of shares, the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such combination shall
be proportionately decreased. Any adjustment under this Section 4€ shall become effective at the close of business on the date the
dividend, subdivision or combination becomes effective.

 

(f) Adjustment
to Number of Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any (i) capital
reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value or from par value
to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of
shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially all of the
Company’s assets to another Person or (v) other similar transaction (other than any such transaction covered by Section Error!
Reference source not found.), in each case which entitles the holders of Common Shares to receive (either directly or upon
subsequent liquidation) stock, securities or assets with respect to or in exchange for Common Shares, each Warrant shall,
immediately after such reorganization, reclassification, consolidation, merger, sale or similar transaction, remain outstanding and
shall thereafter, in lieu of or in addition to (as the case may be) the number of Warrant Shares then exercisable under this
Warrant, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the successor
Person resulting from such transaction to which the Holder would have been entitled upon such reorganization, reclassification,
consolidation, merger, sale or similar transaction if the Holder had exercised this Warrant in full immediately prior to the time of
such reorganization, reclassification, consolidation, merger, sale or similar transaction and acquired the applicable number of
Warrant Shares then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on
the exercisability of this Warrant); and, in such case, appropriate adjustment (in form and substance satisfactory to the Holder)
shall be made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section 4 hereof
shall thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets
thereafter acquirable upon exercise of this Warrant. The provisions of this Section Error! Reference source not found. shall
similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales or similar transactions. The
Company shall not affect any such reorganization, reclassification, consolidation, merger, sale or similar transaction unless, prior
to the consummation thereof, the successor Person (if other than the Company) resulting from such reorganization, reclassification,
consolidation, merger, sale or similar transaction, shall assume, by written instrument substantially similar in form and substance
to this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such shares of stock, securities or assets
which, in accordance with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant.
Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by
the provisions of this Section Error! Reference source not found., the Holder shall have the right to elect prior to the
consummation of such event or transaction, to give effect to the exercise rights contained in Section 2 instead of giving effect to
the provisions contained in this Section Error! Reference source not found. with respect to this Warrant.

 

    10

     

    

 

5. Purchase
Rights. In addition to any adjustments pursuant to Section 4 above, if at any time the Company grants, issues or sells any shares
of Common Shares, Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of Common Shares (the “Purchase Rights”), then the Holder shall be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder would have acquired if the Holder had held the number
of Warrant Shares acquirable upon complete exercise of this Warrant immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Shares are
to be determined for the grant, issue or sale of such Purchase Rights. Anything herein to the contrary notwithstanding, the Holder shall
not be entitled to the Purchase Rights granted herein with respect to any Excluded Issuance.

 

6. Transfer
of Warrant; Transfer of Warrant Shares. Subject to the transfer conditions referred to in the legend endorsed hereon, this Warrant
and all rights hereunder are transferable, in whole or in part, by the Holder without charge to the Holder, upon surrender of this Warrant
to the Company at its then principal executive offices with a properly completed and duly executed Assignment in the form attached hereto
as Exhibit B, together with funds sufficient to pay any transfer taxes described in Section 3(f)(v) in connection with the making
of such transfer. Upon such compliance, surrender and delivery and, if required, such payment, the Company shall execute and deliver a
new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment,
and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly
be cancelled. Notwithstanding the foregoing, the Warrant Shares shall not be sold, transferred, assigned, pledged, or hypothecated, or
be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition
of the Warrant Shares by any person for a period of 180 days immediately following the date hereof.

 

7. Holder
Not Deemed a Shareholder; Limitations on Liability. Except as otherwise specifically provided herein, prior to the issuance to the
Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder shall not
be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company for any purpose, nor shall
anything contained in this Warrant be construed to confer upon the Holder, as such, any of the rights of a Shareholder of the Company
or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of
stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a Shareholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the Holder with copies of the same notices and
other information given to the Shareholders of the Company generally, contemporaneously with the giving thereof to the Shareholders.

 

    11

     

    

 

 8. Replacement on Loss; Division and Combination.

 

(a) Replacement
of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement
or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation
to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and
exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that,
in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.

 

(b) Division
and Combination of Warrant. Subject to compliance with the applicable provisions of this Warrant and the Shareholders Agreement as
to any transfer or other assignment which may be involved in such division or combination, this Warrant may be divided or, following any
such division of this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company
at its then principal executive offices, together with a written notice specifying the names and denominations in which new Warrants are
to be issued, signed by the respective Holders or their agents or attorneys. Subject to compliance with the applicable provisions of this
Warrant and the Shareholders Agreement as to any transfer or assignment which may be involved in such division or combination, the Company
shall at its own expense execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance
with such notice. Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable
in the aggregate for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.

 

9. No
Impairment. The Company shall not, by amendment of its Memorandum of Association or Articles of Association, or through any reorganization,
transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid
the observance or performance of any of the terms to be observed or performed by it hereunder, but shall at all times in good faith assist
in the carrying out of all the provisions of this Warrant and in the taking of all such action as may reasonably be requested by the Holder
in order to protect the exercise rights of the Holder against dilution or other impairment, consistent with the tenor and purpose of this
Warrant.

 

 10. Compliance with the Securities Act.

 

(a) Agreement
to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant, agrees to comply in all respects with the provisions
of this Section 9 and the restrictive legend requirements set forth on the face of this Warrant and further agrees that such Holder shall
not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise hereof except under circumstances
that will not result in a violation of the Securities Act of 1933, as amended (the “Securities Act”). This Warrant
and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Securities Act) shall be stamped or imprinted
with a legend in substantially the following form:

 

“THIS WARRANT AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE
AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION
REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH
EFFECT HAS BEEN RENDERED BY COUNSEL.”

 

    12

     

    

 

(b) Representations
of the Holder. In connection with the issuance of this Warrant, the Holder specifically represents, as of the date hereof, to the
Company by acceptance of this Warrant as follows:

 

(i) The
Holder is an “accredited investor” as defined in Rule 501 of Regulation D promulgated under the Securities Act. The Holder
is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment for its own account and not with a view
towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except pursuant to sales
registered or exempted under the Securities Act.

 

(ii) The
Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted securities”
under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering
and that, under such laws and applicable regulations, such securities may be resold without registration under the Securities Act only
in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule 144 under the Securities Act, as presently
in effect, and understands the resale limitations imposed thereby and by the Securities Act.

 

(iii) The
Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such knowledge
and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant
and the Warrant Shares. The Holder has had an opportunity to ask questions and receive answers from the Company regarding the terms and
conditions of the offering of the Warrant and the business, properties, prospects and financial condition of the Company.

 

11. Registration
of Securities. The Warrant Shares shall be registered by the Company on a resale registration statement on Form F-1 promptly following
the Qualified IPO.

 

12. Warrant
Register. The Company shall keep and properly maintain at its principal executive offices books for the registration of the Warrant
and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on such register as the Holder
thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment, division, combination
or other transfer of the Warrant effected in accordance with the provisions of this Warrant.

 

13. Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to
have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally
recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document (with confirmation of
transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours
of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid.
Such communications must be sent to the respective parties at the addresses indicated below (or at such other address for a party as shall
be specified in a notice given in accordance with this Section 11).

 

    13

     

    

 

If to the Company:

 

with a copy to:

 

If to the Holder:

 

with a copy to:

 

14. Cumulative
Remedies. Except to the extent expressly provided in Section 6 to the contrary, the rights and remedies provided in this Warrant are
cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law,
in equity or otherwise.

 

15. Equitable
Relief. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any of its obligations
under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages would not be an adequate remedy
and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations, the other party hereto shall,
in addition to any and all other rights and remedies that may be available to it in respect of such breach, be entitled to equitable relief,
including a restraining order, an injunction, specific performance and any other relief that may be available from a court of competent
jurisdiction.

 

16. Entire
Agreement. This Warrant, together with the Subscription Agreement, constitutes the sole and entire agreement of the parties to this
Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements,
both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements in the body of this
Warrant, and the Subscription Agreement, the statements in the body of this Warrant shall control.

 

17. Successor
and Assigns. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the parties hereto
and the successors of the Company and the successors and permitted assigns of the Holder. Such successors and/or permitted assigns of
the Holder shall be deemed to be a Holder for all purposes hereunder.

 

18. No
Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company and the Holder and their respective successors and,
in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person
any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.

 

19. Headings.
The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.

 

20. Amendment and
Modification; Waiver. Except as otherwise provided herein, this Warrant may only be amended, modified or supplemented by an
agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions hereof shall be
effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be
construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a
similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising,
any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor shall any
single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the
exercise of any other right, remedy, power or privilege.

 

    14

     

    

 

21. Severability.
If any term or provision of this Warrant is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other term or provision of this Warrant or invalidate or render unenforceable such term or provision in any other
jurisdiction.

 

22. Governing
Law. This Warrant shall be governed by and construed in accordance with the internal laws of the State of New York without giving
effect to any choice or conflict of law provision or rule (whether of the State of York or any other jurisdiction) that would cause the
application of laws of any jurisdiction other than those of the State of York.

 

23. Submission
to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated hereby
may be instituted in the federal courts of the United States of America or the courts of the State of New York in each case located in
the city of New York, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding.
Service of process, summons, notice or other document by certified or registered mail to such party’s address set forth herein shall
be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally
waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to
plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient
forum.

 

24. Waiver
of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS WARRANT IS LIKELY TO INVOLVE COMPLICATED
AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN
RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS WARRANT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

25. Counterparts.
This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to
be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission
shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.

 

26. No
Strict Construction. This Warrant shall be construed without regard to any presumption or rule requiring construction or interpretation
against the party drafting an instrument or causing any instrument to be drafted.

 

[SIGNATURE PAGE FOLLOWS]

 

    15

     

    

 

IN WITNESS WHEREOF, the Company has duly executed this
Warrant on the Original Issue Date.

 

	 	LYTUS TECHNOLOGIES HOLDINGS PTV. LTD.
	 	 	 
	 	By:	                 
	 	Name: 	 
	 	Title:  	 

 

	Accepted and agreed,
	 	 
	By:	     	 
	Name:	 	 
	Title:	 	 

 

    16

     

    

 

Exhibit A

 

Exercise
Agreement

 

    17

     

    

 

NOTICE OF EXERCISE

 

	 	To:	LYTUS TECHNOLOGIES HOLDINGS PTV. LTD.

 

(1) The undersigned hereby elects to purchase
shares of Common Shares of LYTUS TECHNOLOGIES HOLDINGS PTV. LTD. pursuant to the terms of the attached Warrant (the “Warrant”)
and (check the applicable box):

 

__________ Tenders herewith payment of the purchase
price in full, together with all applicable transfer taxes, if any; or

 

__________ Elects to exercise the Warrant on a
“cashless” basis under the limited circumstances described in Section 2(c) of the Warrant.

 

(2) In exercising the Warrant, the undersigned
hereby confirms and acknowledges that the shares of Common Shares to be issued upon exercise hereof are being acquired solely for the
account of the undersigned and not as a nominee for any other party, and for investment and that the undersigned will not offer, sell
or otherwise dispose of any such shares of Common Shares except under circumstances that will not result in a violation of the Securities
Act of 1933, as amended, or any state or foreign securities laws.

 

(3) Please issue a certificate or certificates
representing said shares of Common Shares in the name of the undersigned or in such other name as is specified below:

 

Name: ___________________________

 

Address: _________________________

 

Tax I.D. No. _______________________

 

(4) The undersigned represents that (a) he, she,
or it is the original purchaser from the Corporation of the Warrant or is an “accredited investor” within the meaning of Rule
501(a) under the Securities Act of 1933, as amended, and (b) the aforesaid shares of Common Shares are being acquired for the account
of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned
has no present intention of distributing or reselling such shares.

 

Date: ___________________________

 

Signature: _______________________

 

    18

     

    

Exhibit B

 

Assignment Agreement

 

    19

     

    

 

WARRANT ASSIGNMENT

 

(To be executed by the registered Holder
to effect a transfer of the Warrant)

 

FOR VALUE RECEIVED, does hereby
sell, assign and transfer unto the right to purchase Common Shares, par value $0.01 per share, of Lytus Technologies Holdings PTV. LTD.,
a British Virgin Islands private limited company (“Company”), evidenced by the Warrant and does hereby authorize
the Company to transfer such right on the books of the Company to .

 

Dated:                 ,
20               

 

Signature: _______________________

 

NOTICE: The signature to this form must correspond with
the name as written upon the face of the Warrant without alteration or enlargement or any change whatsoever.

 

 

20Exhibit 10.17

 

THIS SECURED PROMISSORY NOTE
HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND HAS NOT BEEN REGISTERED OR
QUALIFIED FOR SALE OR RESALE UNDER THE SECURITIES LAWS OF ANY STATE. ACCORDINGLY, SUCH NOTE IS NOT FREELY TRANSFERABLE AND MUST BE HELD
UNTIL SUCH TIME AS IT IS EITHER REGISTERED OR QUALIFIED UNDER APPLICABLE LAW OR TRANSFERRED PURSUANT TO AN EXEMPTION THEREFROM.

 

SECURED PROMISSORY NOTE

 

		Note: A-1	 July , 2021

Principal Amount: $1,000,000.00

Purchase Amount:
$880,000.00

 

FOR VALUE RECEIVED, and subject
to the terms and conditions set forth herein, Lytus Technologies Holdings PTV. LTD., a British Virgin Islands private limited company
(the “Maker”), hereby unconditionally promises to pay to the order of ________ (the “Noteholder,”
and together with the Maker, the “Parties”), the principal sum of $1,000,000 (the “Principal Amount”),
which amount is the $880,000 of the purchase price set forth above plus an original issue discount in the amount of $120,000, together
with interest thereon from the date of issuance of this Secured Promissory Note (the “Note,” as the same may be amended,
restated, supplemented, or otherwise modified from time to time in accordance with its terms). Interest will accrue at a simple rate of
seven percent (7%) per annum (the “Interest”), subject to adjustments set forth herein. The principal and accrued interest
of this Note will be due and payable on the date that is the earlier of (i) six (6) months anniversary of this Note, or (ii) a Qualified
IPO, as defined below (the “Maturity Date”). Additionally, the principal and accrued interest of this Note shall accelerate
and become due and payable in accordance with Section 5 of this Note. Terms used but not defined herein, including without limitation
have the meaning set forth in that certain Subscription Agreement by and between the Parties of even date herewith (the “Subscription
Agreement”).

 

WHEREAS, the Parties entered
into the Subscription Agreement pursuant to which the Noteholder agree to sell and the Maker agreed to buy Units.

 

NOW, THEREFORE, in consideration
of the mutual covenants, promises, and obligations set forth herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby expressly acknowledged, the Parties agree as follows:

 

“Person” means
any individual, corporation, limited liability company, trust, joint venture, association, company, limited or general partnership, unincorporated
organization, or other entity.

 

1. Original
Issue Discount. The Principal Amount of this Note is subject to an original issue discount in the amount of twelve percent (12%);
as a result, on the date hereof, the Noteholder shall deliver to the Maker, or its assigns, cash in the amount of $880,000.

 

2. Seniority.
The indebtedness evidenced by this Note and the payment of the Principal Amount and interest shall be Senior (as hereinafter defined)
to, and have priority in right of payment over, all indebtedness of the Maker, now outstanding or hereinafter incurred. “Senior,”
as used herein, shall be deemed to mean that, in the event of any default in the payment of the obligations represented by this Note (after
giving effect to “cure” provisions, if any) or of any liquidation, insolvency, bankruptcy, reorganization or similar proceedings
relating to the Maker, all sums payable on this Note shall first be paid in full, with interest, if any, before any payment is made upon
any other indebtedness, now outstanding or hereinafter incurred, and, in any such event, any payment or distribution of any character
which shall be made in respect of any other indebtedness of the Company, shall be paid over to the Noteholder for application to the payment
hereof, unless and until the obligations under this Note (which shall mean the Principal Amount, any accrued but unpaid interest, and
any costs and expenses payable under this Note) shall have been paid and satisfied in full.

 

3. Title
to the Ownership Interest. Subject to that certain Guaranty and Suretyship Agreement by and between the Parties of even date herewith
(the “Guaranty and Suretyship Agreement, all rights, title, and interest in the Units shall transfer to the Maker upon the
execution of the Subscription Agreement.

 

4. Payments.
All payments will be made in lawful money of the United States of America at the principal office of the Noteholder, or at such
other place as the Noteholder may from time to time designate in writing to the Maker. Payment will be credited first to accrued
interest due and payable, with any remainder applied to the Principal Amount. This Note may not be prepaid or repaid in whole or in
part except as otherwise explicitly set forth herein.

 

     

    

    

 

5. Qualified
IPO. Upon the occurrence of a Qualified IPO (defined below), immediately and without notice, all outstanding indebtedness represented
by the Note shall automatically become due and payable, without presentment, demand, protest or any other notice of any kind, all of which
are hereby expressly waived, anything contained herein or in the Subscription Agreement to the contrary notwithstanding. Notwithstanding
the foregoing, upon the occurrence of a Qualified IPO, the Noteholder shall waive the Interest and the Maker shall have no obligation
pay such Interest to Noteholder. A “Qualified IPO” shall mean the closing within 120 days as of the date hereof of
a firm commitment underwritten public offering of shares of Common Shares of the Maker that results in the Common Shares being traded
on a U.S. national securities exchange.

 

6. Guaranty
and Suretyship; Pledge and Security Agreement. The Maker’s performance of its obligations hereunder is guaranteed by Global
Health Sciences, Inc., a Delaware corporation, as more fully described in the Guaranty and Suretyship Agreement, dated as of an even date
herewith, and secured by a security interest in the assets of Global Health Sciences, Inc. granted pursuant to the Guaranty and Suretyship
Agreement. In addition, the Maker’s performance of its obligations hereunder is secured by a pledge of the Maker’s shares
of the common stock of Global Health Sciences, Inc. pursuant to a Pledge Agreement dated as of an even date herewith.

 

7. Representations
and Warranties. The Maker hereby represents and warrants to the Noteholder on the date hereof as follows:

 

7.1 Existence.
The Maker is a limited liability company duly organized, validly existing and in good standing under the laws of the state of its jurisdiction
of organization.

 

7.2 Power
and Authority. The Maker has the power and authority, and the legal right, to execute and deliver this Note and the Guaranty and Suretyship
Agreement and to perform its obligations hereunder and thereunder.

 

7.3 Authorization;
Execution and Delivery. The execution and delivery of this Note and the Guaranty and Suretyship Agreement by the Maker and the performance
of its obligations hereunder and thereunder have been duly authorized by all necessary limited liability action in accordance with all
applicable Laws. The Maker has duly executed and delivered this Note and the Guaranty and Suretyship Agreement.

 

7.4 Absence
of Material Adverse Change. Since May 25, 2021, there has not been any (a) material adverse change in the business, operations, properties,
condition (financial or otherwise) of the Company, or (b) damage, destruction or loss, whether covered by insurance or not, materially
and adversely affecting the business, properties or condition (financial or otherwise) of the Company, taken as a whole.

 

8. Events
of Default. The occurrence of any of the following shall constitute an Event of Default hereunder:

 

8.1 Failure
to Pay. The Maker fails to pay any amount of the Loan when due; and such failure continues for thirty (30) days after written notice
to the Maker by the Noteholder.

 

8.2 Breach
of Representations and Warranties. Any representation or warranty made or deemed made by the Maker to the Noteholder herein or in
the Guaranty and Suretyship Agreement is incorrect in any material respect as of the date such representation or warranty was made.

 

8.3 Bankruptcy.
Institution of any proceeding by or against the Maker under the provisions of any federal bankruptcy, reorganization, arrangement of debt,
insolvency or receivership laws or similar state or federal laws providing for the relief of debtors, if such proceeding is not dismissed,
bonded or discharged within 30 days following its institution.

 

9. Remedies.
Following the occurrence and during the continuance of any Event of Default, the Noteholder shall be entitled to receive, to the extent
permitted by applicable law, interest on the outstanding principal of, and overdue interest, if any, on, the Notes at a rate per annum
equal to twelve percent (12%).

 

10. Waiver
and Release. The Noteholder, on the Noteholder’s behalf and on behalf of the Noteholder’s heirs, executors, representatives,
administrators, agents, insurers, and assigns (collectively with the Noteholder, the “Releasors”) irrevocably and unconditionally
fully and forever waives, releases, and discharges the Maker, including its members, managers, parents, subsidiaries, affiliates, companies
under common ownership, predecessors, successors, and assigns, and each of their respective officers, directors, employees, in their corporate
and individual capacities (collectively, the “Released Parties”), from any and all claims, demands, actions, causes
of action, judgments, rights, fees, damages, debts, obligations, liabilities, purported rights to distribution of profits, and expenses
(inclusive of attorney’s fees) of any kind whatsoever, whether known or unknown, that Releasors may have or have ever had against
the Released Parties, or any of them, arising out of, or in any way related to the Purported Investment, the Actual Investment, the Investment
Agreement, the Operating Agreement, or the Units.

 

    2

    

    

 

11. Joint
Drafting. The Parties have participated jointly in the negotiation and drafting of this Note and the other Transaction Documents.
Accordingly, the Parties acknowledge and agree that there is no single drafter of this Note or the other Transaction Documents and therefore,
the general rule that ambiguities are to be construed against the drafter is, and shall be, inapplicable. If any language in this Note
is found or claimed to be ambiguous, each party shall have the same opportunity to present evidence as to the actual intent of the parties
with respect to any such ambiguous language without any inference or presumption being drawn against any party.

 

 12. Miscellaneous.

 

12.1 Notices.
All notices, requests, consents, claims, demands, waivers, and other communications hereunder shall be in writing and shall be deemed
to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a
nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or email of a PDF document (with confirmation
of transmission) if sent during normal business hours of the recipient, and on the next business day if sent after normal business hours
of the recipient or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid.
Such communications must be sent to the respective parties at the following addresses they may from time to time provide.

 

12.2 Expenses.
The Parties shall be responsible for their own costs, expenses, and fees (including reasonable expenses and fees of its external counsel)
incurred in connection with the transactions contemplated hereby, including the negotiation, documentation, and execution of this Note
and the Guaranty and Suretyship Agreement and the enforcement of rights hereunder and thereunder.

 

12.3 Governing
Law. This Note and the Guaranty and Suretyship Agreement shall be governed by the laws of the State of New York.

 

12.4 Arbitration.
Any controversy or claim arising out of or relating to this Note or the Guaranty and Suretyship Agreement, to the extent not waived by
the terms of this Note, shall be settled by arbitration administered by the American Arbitration Association under its Commercial Arbitration
Rules. The number of arbitrators shall be one. The place of arbitration shall be New York, New York. New York law shall apply. Judgement
on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The Parties shall share the costs of
such arbitration evenly.

 

12.5 Counterparts;
Integration; Effectiveness. This Note and any amendments, waivers, consents, or supplements hereto may be executed in counterparts,
each of which shall constitute an original, but all taken together shall constitute a single contract. This Note and the Guaranty and
Suretyship Agreement constitute the entire contract between the Parties with respect to the subject matter hereof and supersede all previous
agreements and understandings, oral or written, with respect thereto. Delivery of an executed counterpart of a signature page to this
Note by facsimile or in electronic (i.e., “pdf” or “tif”) format shall be effective as delivery of a manually
executed counterpart of this Note or the Guaranty and Suretyship Agreement, as applicable.
If any terms of this Note conflict with those of the Guaranty and Suretyship Agreement, the terms of this Note will govern.

 

12.6 Successors
and Assigns. This Note may not be assigned, transferred, or negotiated by the Noteholder to any Person, defined below, at any
time, without notice to or the consent of the Maker. Person means any individual, corporation, limited liability company, trust,
joint venture, association, company, limited or general partnership, unincorporated organization, or other entity. The Maker may
assign or transfer this Note or any of its rights hereunder without the prior written consent of the Noteholder. This Note shall
inure to the benefit of and be binding upon the parties hereto and their permitted assigns.

 

12.7 Amendments
and Waivers. This Note may only be amended, modified, or supplemented by an agreement in writing signed by each party hereto.

 

12.8 No
Waiver. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed
by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach, or default
not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that
waiver. No failure to exercise, or delay in exercising, any right, remedy, power, or privilege arising from this Note shall operate or
be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude
any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

 

12.9 Severability.
If any term or provision of this Note or the Guaranty and Suretyship Agreement is invalid, illegal, or unenforceable in any jurisdiction,
such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Note or the Guaranty and Suretyship
Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction.

 

[SIGNATURE PAGE FOLLOWS]

 

    3

    

    

 

IN WITNESS WHEREOF, the Maker has executed this Note as
of July , 2021.

 

	 	LYTUS TECHNOLOGIES HOLDINGS PTV. LTD.
	 	 	 
	 	By	                  
	 	Name:	 
	 	Title:	 

 

	 	Acknowledged and agreed:
	 	 	 
	 	By	                  
	 	Name:	 
	 	Title:	 

 

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]